These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38607760)
1. The Association Between Physical Activity/Heart Rate Variability Data Obtained Using a Wearable Device and Timed Motor Functional Tests in Patients with Duchenne Muscular Dystrophy: A Pilot Study. Nakamura A; Matsumura T; Takeshima Y; Kuru S; Imazaki M; Nonomura H; Kaiya H J Neuromuscul Dis; 2024; 11(3):715-724. PubMed ID: 38607760 [TBL] [Abstract][Full Text] [Related]
2. Appendicular lean mass index and motor function in ambulatory patients with Duchenne muscular dystrophy. Kiefer M; Townsend E; Goncalves C; Shellenbarger KC; Gochyyev P; Wong BL Muscle Nerve; 2024 Aug; 70(2):226-231. PubMed ID: 38837739 [TBL] [Abstract][Full Text] [Related]
3. Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy. Rabbia M; Guridi Ormazabal M; Staunton H; Veenstra K; Eggenspieler D; Annoussamy M; Servais L; Strijbos P J Neuromuscul Dis; 2024; 11(3):701-714. PubMed ID: 38640165 [TBL] [Abstract][Full Text] [Related]
4. Assessment of cardiac autonomic function in patients with Duchenne muscular dystrophy using short term heart rate variability measures. Dhargave P; Nalini A; Abhishekh HA; Meghana A; Nagarathna R; Raju TR; Sathyaprabha TN Eur J Paediatr Neurol; 2014 May; 18(3):317-20. PubMed ID: 24445161 [TBL] [Abstract][Full Text] [Related]
5. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Mazzone E; Martinelli D; Berardinelli A; Messina S; D'Amico A; Vasco G; Main M; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Carlesi A; Bonetti AM; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Pasquini E; Bruno C; Vita G; de Waure C; Bertini E; Mercuri E Neuromuscul Disord; 2010 Nov; 20(11):712-6. PubMed ID: 20634072 [TBL] [Abstract][Full Text] [Related]
6. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests. Miller NF; Alfano LN; Iammarino MA; Connolly AM; Moore-Clingenpeel M; Powers BR; Tsao CY; Waldrop MA; Flanigan KM; Mendell JR; Lowes LP Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653 [TBL] [Abstract][Full Text] [Related]
7. Comparison of motor proficiency and functional ambulation in Duchenne muscular dystrophy with healthy peers. Yildiz S; Sahin S; Bulut N; Tunca Yilmaz O; Karaduman AA; Akel BS Somatosens Mot Res; 2020 Dec; 37(4):252-256. PubMed ID: 32583706 [TBL] [Abstract][Full Text] [Related]
8. Use of a wearable device to assess sleep and motor function in Duchenne muscular dystrophy. Siegel BI; Cakmak A; Reinertsen E; Benoit M; Figueroa J; Clifford GD; Phan HC Muscle Nerve; 2020 Feb; 61(2):198-204. PubMed ID: 31725915 [TBL] [Abstract][Full Text] [Related]
9. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570 [TBL] [Abstract][Full Text] [Related]
11. Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids. Duong T; Canbek J; Fernandez-Fernandez A; Henricson E; Birkmeier M; Siener C; Tesi Rocha C; McDonald C; Gordish-Dressman H; J Neuromuscul Dis; 2022; 9(1):147-159. PubMed ID: 34719507 [TBL] [Abstract][Full Text] [Related]
12. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. McDonald CM; Henricson EK; Abresch RT; Florence J; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz SW Muscle Nerve; 2013 Sep; 48(3):357-68. PubMed ID: 23674289 [TBL] [Abstract][Full Text] [Related]
13. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy. Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260 [TBL] [Abstract][Full Text] [Related]
14. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337 [TBL] [Abstract][Full Text] [Related]
15. Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys. Stimpson G; Ridout D; Wolfe A; Milev E; O'Reilly E; Manzur A; Sarkozy A; Muntoni F; Cole TJ; Baranello G; J Neuromuscul Dis; 2024; 11(1):153-166. PubMed ID: 37980680 [TBL] [Abstract][Full Text] [Related]
16. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy. Kempen JC; Harlaar J; van der Kooi AJ; de Groot IJ; van den Bergen JC; Niks EH; Verschuuren JJ; Brehm MA Neuromuscul Disord; 2014 Mar; 24(3):216-21. PubMed ID: 24365209 [TBL] [Abstract][Full Text] [Related]
17. Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy. Nagy S; Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Bieri O; Vuillerot C; Bonati U; Fischer D J Vis Exp; 2019 Jan; (143):. PubMed ID: 30688316 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment. Romano A; Favetta M; Schirinzi T; Summa S; Minosse S; D'Amico A; Catteruccia M; Petrarca M; Castelli E; Bertini E; Vasco G Neuromuscul Disord; 2019 Dec; 29(12):920-929. PubMed ID: 31791868 [TBL] [Abstract][Full Text] [Related]
19. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial. Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051 [TBL] [Abstract][Full Text] [Related]
20. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. McDonald CM; Henricson EK; Abresch RT; Florence JM; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz S Muscle Nerve; 2013 Sep; 48(3):343-56. PubMed ID: 23681930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]